欢迎访问《中国实验方剂学杂志》编辑部网站!
三黄散瘀巴布剂的基质配方优选
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

浙江省科技厅科技计划项目(2007C23020);浙江省中药现代化专项资金项目(浙财企字[2008]268号);浙江省中医药管理局项目(2006C038)


Optimization of Matrix Formulation of Sanhuang Sanyu Cataplasm
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的: 优选三黄散瘀巴布剂的基质配方。 方法: 以巴布剂的外观性状和黏力为评价指标,采用单因素试验和正交试验优选三黄散瘀巴布剂的基质配方。 结果: 三黄散瘀巴布剂的较优基质配方为NP-700-K90-甘油(0.5∶0.4∶6)。取大黄、黄芩合提浓缩液加入卡波姆-u10NF得质量浓度0.02 g·mL-1溶液,溶胀过夜,作为A相,将聚丙烯酸钠0.5 g和聚乙烯吡咯烷酮0.4 g加入到6 g甘油中作为B相,将三氯化铝和柠檬酸加入到水中作为C相,黄柏单提浓缩液作为D相,将上述4相按A-B-C-D(10∶3∶3∶5)充分混合搅匀,搅拌15 min,涂布,盖上防黏层。 结论: 所优选三黄散瘀巴布剂的基质配方简单、稳定,可推广于大生产应用。

    Abstract:

    Objective:To optimize matrix formulation of Sanhuang Sanyu cataplasm. Method: Taking appearance and adhesion of cataplasm as evaluation indexes,matrix formulation of Sanhuang Sanyu cataplasm was optimized by single factor test and orthogonal test. Result: Optimized matrix formulation of Sanhuang Sanyu cataplasm was NP-700-K90-glycerol(0.5∶0.4∶6).0.02 g·mL-1 solution was received by adding carbomer-u10NF into mixed extraction concentrated liquid of Rheum palmatum and Scutellaria baicalensis,swelling overnight, as A phase,0.5 g sodium polyacrylate and 0.4 g PVP were added to 6 g glycerol as B phase,aluminum chloride and citric acid were added to water as C phase,single extraction concentrated liquid of Phellodendron chinense was as D phase,four phases was fully mixed with A-B-C-D(10∶3∶3∶5), stirred 15 min, coating,covered with anti-sticking layer. Conclusion: Optimized matrix formulation of Sanhuang Sanyu cataplasm was simple,stable and feasible,which could be applied to industrial production.

    参考文献
    相似文献
    引证文献
引用本文

尹华.三黄散瘀巴布剂的基质配方优选[J].中国实验方剂学杂志,2012,18(24):24~27

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2012-07-11
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2012-12-12
  • 出版日期:

地址:北京东直门内南小街16号

邮编:100700

电话:010-84076882

E-mail:syfjx_2010@188.com

中国实验方剂学杂志 ® 2021 版权所有

技术支持:北京勤云科技发展有限公司